Skip to main content
Frontiers in Pharmacology logoLink to Frontiers in Pharmacology
. 2021 Feb 8;11:637775. doi: 10.3389/fphar.2020.637775

Corrigendum: Linking the Declarations of Helsinki and of Taipei: Critical Challenges of Future-Oriented Research Ethics

Chieko Kurihara 1,*, Varvara Baroutsou 2, Sander Becker 3, Johan Brun 4, Brigitte Franke-Bray 5, Roberto Carlesi 6, Anthony Chan 7, Luis Francisco Collia 8, Peter Kleist 9, Luís Filipe Laranjeira 10, Kotone Matsuyama 11, Shehla Naseem 12, Johanna Schenk 13, Honorio Silva 14, Sandor Kerpel-Fronius 15; on behalf of Working Group on Ethics of the International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine
PMCID: PMC7897664  PMID: 33628190

In the original article, there were errors.

In the abstract, “(Declaration of Taipei)” was deleted; in the 1 Introduction section, “1948, in its second year” was changed to “in its second and third years”; in the 4 Individual Participant Data (IPD) Sharing and Trial Registration Requirement section, parenthesis before and after “Supplementary Material”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Author Contributions

All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.

Conflict of Interest

JB is an employee of LIF; AC is an employee of Pfizer Biopharmaceuticals Group; LC is an employee of Craveri Pharma; LF is an employee of Eli Lilly & Co.; SN is an employee of Ferozsons Laboratories Ltd.; JS is an executive consultant of PPH plus GmbH & Co. KG, Hochheim am Main.

The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.


Articles from Frontiers in Pharmacology are provided here courtesy of Frontiers Media SA

RESOURCES